BTG : Trial Finds Patients Receiving CroFab Antivenom Less Likely to Use Opioids for Pain Control

Press/Media

Period	30 Apr 2019

Media coverage

Title	BTG : Trial Finds Patients Receiving CroFab Antivenom Less Likely to Use Opioids for Pain Control
Media name/outlet	MarketScreener.com
Country/Territory	United States
Date	30/04/19
URL	https://www.marketscreener.com/BTG-PLC-9583552/news/BTG-Trial-Finds-Patients-Receiving-CroFab-Antivenom-Less-Likely-to-Use-Opioids-for-Pain-Control-28505437/
Persons	Charles Gerardo